These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19164801)

  • 21. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway.
    Vogel C; Bauer A; Wiesnet M; Preissner KT; Schaper W; Marti HH; Fischer S
    J Cell Physiol; 2007 Jul; 212(1):236-43. PubMed ID: 17311300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
    Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
    J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
    Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
    Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy.
    Yau TM; Li G; Zhang Y; Weisel RD; Mickle DA; Li RK
    Ann Thorac Surg; 2005 Jun; 79(6):2056-63. PubMed ID: 15919309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse.
    Li Z; Chen XD; Ni SK; Li JW; Lin MS
    Chin J Traumatol; 2004 Feb; 7(1):56-61. PubMed ID: 14728822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation.
    Shibata M; Suzuki H; Nakatani M; Koba S; Geshi E; Katagiri T; Takeyama Y
    Histochem Cell Biol; 2001 Dec; 116(6):471-81. PubMed ID: 11810189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of neointimal hyperplasia after vascular injury by blocking 4-1BB/4-1BB ligand pathway.
    Karube A; Suzuki J; Haraguchi G; Maejima Y; Saiki H; Kosuge H; Isobe M; Uede T
    J Med Dent Sci; 2008 Jun; 55(2):207-13. PubMed ID: 19697509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice.
    Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L
    Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells.
    Chandra A; Angle N
    Surgery; 2005 Oct; 138(4):780-7. PubMed ID: 16269309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
    Malabanan KP; Kanellakis P; Bobik A; Khachigian LM
    Circ Res; 2008 Aug; 103(4):378-87. PubMed ID: 18617696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
    Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
    Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of vascular endothelial growth factor and its receptors in the porcine corpus luteum during the estrous cycle and early pregnancy.
    Kaczmarek MM; Kowalczyk AE; Waclawik A; Schams D; Ziecik AJ
    Mol Reprod Dev; 2007 Jun; 74(6):730-9. PubMed ID: 17120307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
    Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
    Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-Myb represses vascular smooth muscle cell collagen gene expression and inhibits neointima formation after arterial injury.
    Hofmann CS; Sullivan CP; Jiang HY; Stone PJ; Toselli P; Reis ED; Chereshnev I; Schreiber BM; Sonenshein GE
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1608-13. PubMed ID: 15256398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth.
    Muramatsu M; Yamamoto S; Osawa T; Shibuya M
    Cancer Res; 2010 Oct; 70(20):8211-21. PubMed ID: 20924106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
    Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways.
    Sun JY; Li C; Shen ZX; Zhang WC; Ai TJ; Du LJ; Zhang YY; Yao GF; Liu Y; Sun S; Naray-Fejes-Toth A; Fejes-Toth G; Peng Y; Chen M; Liu X; Tao J; Zhou B; Yu Y; Guo F; Du J; Duan SZ
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):874-85. PubMed ID: 26966277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation.
    Subramanian P; Karshovska E; Reinhard P; Megens RT; Zhou Z; Akhtar S; Schumann U; Li X; van Zandvoort M; Ludin C; Weber C; Schober A
    Circ Res; 2010 Jul; 107(1):96-105. PubMed ID: 20360252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.